Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05687487

Residual or Recurrent Obstruction After Septal Myectomy

Conditions: Hypertrophic Obstructive Cardiomyopathy

Sex: All
Ages: N/A – 14 Years
Enrollment: 56
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital

Summary

The goal of this observational study is to report the outcomes after septal myectomy in young children and infants and identify the mechanisms of residual or recurrent obstruction after surgery. in The main question[s] it aims to answer are:What is the early and mid-term results of septal myectomy in young children and infants with severe and extensive obstructive hypertrophic cardiomyopathy (HCM)?What are the mechanisms of residual or recurrent obstruction?Echocardiography and clinical course of children and infants under the age of 14 who underwent septal myectomy for hypertrophic obstructive cardiomyopathy from January 2013 to December 2020 will be followed up.

Eligibility Criteria

Inclusion Criteria:Clinical diagnosis of hypertrophic obstructive cardiomyopathy (HOCM)Age young than 14 yearsPatients who have undergone septal myectomyExclusion Criteria:older than 14 years old;secondary left ventricular hypertrophy (LVH) related to subaortic stenosis or aortic stenosis.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05687487). StuddyBuddy aggregates publicly available trial information.